In practice, the clinical trials for cagrilintide report tolerability outcomes and adverse event patterns alongside efficacy endpoints, because these factors influence dose escalation and continuation within a protocol
Q: Do I need PCT after GH peptides
Phase 2 results (48 weeks): 1mg dose: 8.7% average weight loss 4mg dose: 17.1% average weight loss 8mg dose: 22.8% average weight loss 12mg dose: 24.2% average weight loss Placebo: 2.1% average weight loss These numbers came from a 48-week study period, six months shorter than the 72-week SURMOUNT trials
Available in custom dosing up to 100g (100,000mg), our wellness infusions feature options like high-dose vitamin C, Myers cocktail, and NAD+ infusions
Osteoporosis, inflammation and ageing
It is crucial to follow the dosage recommendations provided by a healthcare professional and monitor for any adverse effects